Drug
POMx
POMx is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph phase_4
1
25%
Ph not_applicable
1
25%
Ph phase_2
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)
Trials by Status
unknown125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Pomegranate Extract and Memory
NCT01950221
completednot_applicable
Effects of Pomegranate Extract on Intestinal Flora
NCT02370641
completedphase_2
Cognitive Impact of Pomegranate Polyphenols Following Ischemic Stroke
NCT02442804
unknownphase_4
The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the Development of Atherosclerosis in Diabetic Patients
NCT00470808
Clinical Trials (4)
Showing 4 of 4 trials
NCT01950221Phase 2
Pomegranate Extract and Memory
NCT02370641Not Applicable
Effects of Pomegranate Extract on Intestinal Flora
NCT02442804Phase 2
Cognitive Impact of Pomegranate Polyphenols Following Ischemic Stroke
NCT00470808Phase 4
The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the Development of Atherosclerosis in Diabetic Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4